Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Beyond placebo purism: rebalancing evidence standards for digital therapeutics
1
Zitationen
2
Autoren
2026
Jahr
Abstract
Introduction Druart and Blease 1 raise an important question, especially in light of accelerated development of AI chatbots in digital medicine: what is the appropriate comparator in digital health trials?
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.245 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.102 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.468 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.429 Zit.